News
- Author:
- Heidi Splete
Publish date: February 15, 2024
In the study, a CBC was the most common pretreatment test across treatments, performed in 41%-69% of patients before starting treatment with a syst...
News
- Author:
- Heidi Splete
Publish date: February 15, 2024
Oral agents scored higher on patient satisfaction despite increased side effects.
News
- Author:
- Heidi Splete
Publish date: February 14, 2024
Approximately 40% of women with an adverse pregnancy outcome in their first pregnancy developed an APO in their second pregnancy.
News
- Author:
- Heidi Splete
Publish date: February 13, 2024
Decreased messenger RNA sequencing expression of SMAD4 was associated with lower overall survival.
News
- Author:
- Heidi Splete
Publish date: February 13, 2024
Revised guidance promotes vaporized hydrogen peroxide as a sterilization method to reduce ethylene oxide use.
News
- Author:
- Heidi Splete
Publish date: February 9, 2024
Survey results highlight a gap in residency education and the lack of consensus on addressing a common patient concern.
News
- Author:
- Heidi Splete
Publish date: February 8, 2024
A new nodal classification system eliminates a rare nodal category and focuses on lymph node size, number, and extent.
News
- Author:
- Heidi Splete
Publish date: February 6, 2024
New study finds no difference in long-term back pain from axSpA treated with NSAIDs and non-axSpA back pain.
News
- Author:
- Heidi Splete
Publish date: February 2, 2024
Energy-adjusted dietary inflammatory index scores were not associated with tibial cartilage volume loss or overall bone marrow loss.
News
- Author:
- Heidi Splete
Publish date: February 2, 2024
“This study supports the warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing g...
News
- Author:
- Heidi Splete
Publish date: February 1, 2024
Seal of Acceptance is designed to identify products suitable for sensitive and redness-prone skin.
News
- Author:
- Heidi Splete
Publish date: January 30, 2024
Ibuprofen treatment within 72 hours of birth did not reduce risk of death or bronchopulmonary dysplasia.
News
- Author:
- Heidi Splete
Publish date: January 25, 2024
More than half of patients with RA lacked baseline assessment of disease when they began TNFi therapy.
News
- Author:
- Heidi Splete
Publish date: January 25, 2024
Though a small sample size, patients with severe OSA had early bone loss, compared with mild or moderate OSA.
News
- Author:
- Heidi Splete
Publish date: January 23, 2024
Patients with breast cancer with a high risk of recurrence showed significant improvement with adjuvant abemaciclib compared with endocrine therapy...
